Elizabeth Park

Vice President of Investor Relations, Life Sciences Team at Frazier Healthcare Partners

Elizabeth Park

Elizabeth Park

Vice President of Investor Relations, Life Sciences Team at Frazier Healthcare Partners

Biography

Presently, ELIZABETH PARK holds the position of Vice President of Investor Relations at Frazier Management LLC.

Overview
RelSci Relationships

91

Contact Data
Trying to get in touch with Elizabeth Park? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Elizabeth Park likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Frazier Healthcare Partners

Relationship likelihood: Strong

General Partner, Growth Buyout Team at Frazier Healthcare Partners

Relationship likelihood: Strong

Managing Partner, Growth Buyout Group at Frazier Healthcare Partners

Relationship likelihood: Strong

Chairman at Frazier Healthcare Partners

Relationship likelihood: Strong

Managing Partner, Growth Buyout Team at Frazier Healthcare Partners

Relationship likelihood: Strong

Chief Financial Officer & Partner at Frazier Healthcare Partners

Relationship likelihood: Strong

Executive Partner, Growth Buyout Team at Frazier Healthcare Partners

Relationship likelihood: Strong

Executive Partner, Growth Buyout Team at Frazier Healthcare Partners

Relationship likelihood: Strong

Executive Partner, Growth Buyout Team at Frazier Healthcare Partners

Relationship likelihood: Strong

Executive Partner, Growth Buyout Team at Frazier Healthcare Partners

Relationship likelihood: Strong

Paths to Elizabeth Park
Potential Connections via
Relationship Science
You
Elizabeth Park
Vice President of Investor Relations, Life Sciences Team at Frazier Healthcare Partners
Education
B.A. in Mass Communications

University of California Berkeley National rankings: In a National Research Council analysis of 212 doctoral programs at American universities, 48 Berkeley programs place among the top 10 nationwide. Faculty awards and honors: There are 8 Nobel Laureates, 32 MacArthur Fellows, and 4 Pulitzer Prize winners among the current faculty. History of UC Berkeley: Historical highlights, arranged by topic, following the campus's development — from UC's founding in 1868 to a turn-of-the-century building boom, a research explosion in the 1930s, the Free Speech Movement of the '60s, and Berkeley's key role today in science and technology revolutions. Timeline of discoveries and contributions by UC Berkeley scholars. Traditions of Cal: Who was the Angel of Death? What's with the "Big C" up there in the hills — and why is it sometimes green? Who wears Oski's jolly bear head and size 54 yellow sweater? Tours and webcams: Check out what's happening on Sproul Plaza, the campus's true heart. See stunning live views of the Bay Area from the Lawrence Hall of Science's perch in the Berkeley hills. Chancellor and administration: Information on Chancellor Robert Birgeneau, Executive Vice Chancellor and Provost George W. Breslauer, and how the university is organized. Organizational charts are included. UC System overview and links: On the campuses, laboratories, and medical centers that comprise UC's public educational system, as well as UC's K-12 partnerships, economic impact, and agriculture and environmental resources.

Career History
Vice President of Investor Relations, Life Sciences Team
Current

Frazier Management invests in lower middle-market healthcare companies with $5-50 million in EBITDA and makes equity commitments ranging from $30-350 million. Investments take the form of buyouts, recapitalizations and corporate carveouts.

Product Project Manager, Global Regulatory Affairs & Safety Department
Prior

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Associate Project Manager
Prior

MacuSight, Inc. develops and manufactures pharmaceuticals products. The firm engages in developing therapeutics for the treatment of severe ocular diseases and conditions. It offers sirolimus, a therapeutic for the treatment and prevention of wet age-related macular degeneration, as well as for the treatment of diabetic macular edema; and related compounds and other select therapeutics in the eye, as well as minimally-invasive ocular formulations. The company was founded in 2003 and is headquartered in Union City, CA.

Other Affiliations

Elizabeth Park is affiliated with Frazier Healthcare Partners, Amgen, Inc., MacuSight, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Elizabeth Park. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Elizabeth Park's profile does not indicate a business or promotional relationship of any kind between RelSci and Elizabeth Park.